Quironsalud Madrid
| Turchia | Austria | Spagna | |
| Trachelectomia uterina | da $5,500 | da $14,500 | da $10,000 |
| Terapia protonica per il cancro alla prostata | da $30,000 | da $80,000 | da $70,000 |
| Terapia protonica per il cancro al seno | da $30,000 | da $55,000 | da $85,000 |
| Terapia con protoni | da $70,000 | da $80,000 | da $25,641 |
| Radioterapia per il cancro colorettale | da $7,000 | da $12,000 | da $10,000 |
Il medico possiede una laurea in Medicina presso l'Università Complutense di Madrid e un dottorato presso l'Università di Barcellona. Specializzandosi in Ematologia e Oncologia Pediatrica presso l'Università del Maryland, il medico è esperto nel trattamento di tumori ossei e cerebrali, nonché di leucemia e malattie ematologiche.<\/p>
Con oltre due decenni di esperienza, il medico attualmente dirige l'Unità di Ematologia e Oncologia Pediatrica presso l'Ospedale HM Montepríncipe, concentrandosi sulla cura di bambini e adolescenti. In precedenza, il medico ha ricoperto la stessa posizione presso l'Ospedale Universitario Clínica San Rafael ed è autore di numerose pubblicazioni scientifiche.<\/p>
Il medico è un oncologo pediatrico con 37 anni di esperienza, specializzato nel trattamento dei disturbi del sangue e nell'esecuzione di procedure come i trapianti di midollo osseo e la terapia ablativa. Attualmente, il medico è Capo dell'Emato-Oncologia Pediatrica presso l'Ospedale Universitario Quironsalud Madrid.<\/p>
Con un prolifico curriculum accademico, il medico ha curato 14 libri, contribuito a 75 capitoli di libri e presentato a oltre 200 conferenze. Il medico è membro di diverse associazioni professionali, tra cui l'Associazione Spagnola di Ematologia Pediatrica e l'Associazione Spagnola di Oncologia Pediatrica.<\/p>
Il medico tratta un'ampia gamma di condizioni, tra cui leucemia, linfoma, mieloma multiplo e vari disturbi ematologici e autoimmuni.<\/p>
Il medico è responsabile della gestione delle malignità toraciche e supervisiona le sperimentazioni sul cancro toracico presso il Dipartimento di Oncologia. La loro ricerca si concentra sull'ottimizzazione della chemioterapia nelle fasi iniziali della malattia, sulla valutazione di nuove terapie, sull'esplorazione di approcci farmacogenomici, sull'integrazione dell'immunoterapia per il cancro ai polmoni e sull'indagine dei meccanismi di resistenza agli inibitori della tirosina-chinasi.<\/p>
Con una laurea in medicina e un dottorato in oncologia medica presso l'UAB, il medico è membro di diverse società oncologiche prestigiose, tra cui ESMO, ASCO e IASLC. Hanno pubblicato numerosi articoli sottoposti a revisione paritaria e capitoli di libri sulle malignità toraciche e hanno ricoperto posizioni di insegnamento presso l'UAB e UVicc-UCC.<\/p>
Medical Director of the University of Navarra Clinic
Prof. of hematology and hemotherapy
Spain offers multidisciplinary adenocarcinoma treatments through surgery, high-precision radiation, and oncology protocols within JCI-accredited centers. Major options include robotic-assisted surgery for resectable tumors and advanced Proteus ONE proton therapy. Specialized approaches like HIPEC and personalized targeted therapies are standard at leading academic hospitals.
Bookimed Expert Insight: Spain’s oncology market shows a clear focus on high-volume efficiency. Hospital Universitario HM Madrid manages over 2.3 million outpatients annually. This massive case volume allows specialized centers like the Proton Therapy Centre Quironsalud to accumulate expertise quickly. For example, their specialists have already managed over 900 cases with the Proteus ONE system since 2019.
Patient Consensus: Patients emphasize the need for a second opinion before surgery to confirm tumor staging. Many note that choosing between surgery-first or chemotherapy-first protocols significantly impacts their long-term quality of life.
Spain hosts globally recognized oncology centers like Quironsalud Madrid and Centro Médico Teknon. These JCI-accredited facilities lead in adenocarcinoma care using robotic surgery and proton therapy. Top institutions often feature specialized units for lung, prostate, and colorectal cancers, ensuring high success rates for local and international patients.
Bookimed Expert Insight: Patient volume indicates clinic prestige and safety in Spain. HM Hospitales and Hospital HM Nou Delfos manage 400,000+ patients annually. High volume often correlates with better outcomes in complex surgeries. For example, Dr. Antonio Alcaraz at Hospital Quiron Barcelona performs advanced robotic procedures. These high-capacity centers typically offer more robust clinical trial access than smaller boutique clinics.
Patient Consensus: Patients emphasize finding clinics with integrated tumor boards for stage IV cases. Reliable pathology reviews and quick access to targeted therapies like immunotherapy are also highly valued.
International patients can join adenocarcinoma clinical trials in Spain. Success often depends on residency status and trial phase. Most public trials require European Union (EU) residency or a specific sponsor visa. Private networks like Quironsalud frequently facilitate access for non-EU participants through dedicated international departments.
Bookimed Expert Insight: Quironsalud Madrid stands out for international trial seekers. Unlike many public facilities, it explicitly offers opportunities for patients to receive treatment for free by participating in clinical trials. This clinic is a strategic choice because it combines high-tech diagnostics with a specific administrative path for international trial enrollment.
Patient Consensus: Patients note that private bridges like Quironsalud are more successful at handling paperwork for international applicants. Many emphasize that you should prepare for a three-to-six-month stay to meet the strict trial follow-up requirements.
To prepare for adenocarcinoma treatment in Spain, you must organize comprehensive medical records and legal documents. Ensure you have histological reports, digital DICOM imaging, and oncological summaries. Non-EU patients require a hospital invitation letter, specialized travel insurance, and proof of financial means for visa approval.
Bookimed Expert Insight: While many expect straightforward admissions, Spanish JCI-accredited centers like Clinica Universidad de Navarra or Hospital Quiron Barcelona often require a second histopathology revision. Our data shows that top researchers like Dr. Carme Ares may request original glass slides for specialized proton therapy planning. Sending these by courier before your flight can save up to 7 days during the diagnostic phase in Spain.
Patient Consensus: Patients note it is vital to carry a 3-month supply of ongoing medications in original packaging. They also emphasize that having notarized Spanish translations avoids the risk of customs officials seizing unlabeled oncology drugs.
Proton therapy is safer than standard radiotherapy because it eliminates the exit dose of radiation. While X-rays pass through the body, proton beams stop at a specific depth. This protects healthy tissue and critical organs from collateral damage during adenocarcinoma treatment.
Bookimed Expert Insight: While Spain's first center, Proton Therapy Centre Quironsalud, uses the advanced Proteus ONE system, it is important to note that proton therapy is not always a faster treatment. For example, brain tumor packages involve a 25-day stay, while lung or esophageal cases require 45 to 60 days. This longer duration often reflects the complexity of cases where protons are chosen specifically to protect vital organs near the tumor site.
Patient Consensus: Patients note it is critical to compare dosimetry plans between protons and photons to see how much radiation is actually spared. Many emphasize that this technology is life-changing for preserving urinary and heart function compared to traditional methods.
Spanish hospitals offer specialized oncology bundles featuring advanced diagnostics and high-precision treatments for adenocarcinoma. These arrangements typically include personalized treatment planning through PET/CT scans and genomic profiling. Specialized protocols like Proteus ONE proton therapy and robotic surgery are common in JCI-accredited facilities.
Bookimed Expert Insight: Spanish oncology centers often differentiate their packages through extended hotel partnerships rather than hospital stays. For instance, proton therapy protocols at Quironsalud include up to 45–60 days of hotel stay coordination. This is because these advanced treatments are outpatient-based. This structure allows patients to recover in a more comfortable environment while remaining close to the clinic.
Patient Consensus: Patients note that having a dedicated individual chamber during surgical recovery makes a significant difference. They also appreciate receiving comprehensive medical reports in English to share with their doctors at home.